Autoinjectors & pens

Nemera has a recognized expertise in the development and manufacturing of respiratory drug delivery devices, such as Dry Powder Inhalers (DPIs), pressurized Metered Dose Inhalers (pMDIs) and dose counters.

More than ten million asthmatics rely everyday on devices manufactured by Nemera.

From early-stage concept development to manufacturing we are truly a holistic partner in inhalation.

With a long-standing know-how in inhalation delivery, we are today the leader in the Dry Powder Inhalers (DPIs) manufacturing business.
Our expertise covers Dry Powder Inhalers (reservoir, b...

Safe’n’Sound® (1ml & 2.25ml) is a highly customizable platform of add-on passive safety devices for prefilled syringes. It helps in preventing needlestick injuries, providing user-friendly protection for healthcare professionals and patients or caregivers.
Ergonomically designed, Safe’n’Sound® is ...

Symbioze is specifically tailored to administer complex drugs, such as biologic therapies, thanks to a highly engineered, reliable drug delivery system. It is suitable for various drug platforms and compatible with market-proven cartridges, as well as standard manufacturing processes. The cartridge is pr...

Our portfolio of disposable pens includes variable and fixed dose devices for automatic and manual drug administration, combining modern design with high intuitiveness of use for multidose therapies.


PENVARIO – Dedicated to manufacturing of disposable, variable-dose pen injectors

Our reusable pens ensure the application of proven technological solutions with reliability, intuitiveness as well as ease-of-use.

Implants are fragile and insertion into the body requires caution. Nemera developed a portfolio of devices to deliver implants with integrated needlestick protection.

There is two types of implanters:

- Safety depot syringe with telescopic plunger rod
- Safety retro injector for ...

Sof’Bag+ is an airless pouch-in-bottle packaging solution for prescription (Rx) and over-the-counter (OTC) formulations for dermal and transdermal application.

Sof’Airless XS+ is a protective mini-airless system for small dose applications and sampling.
It is the solution for trial sizes or local treatments with very little skin surface to cover.
It targets Rx and OTC dermal gels and creams and is already used for cold sore treatments.

We offer millimeter solutions in medicine applicators and dispensers, being today a global reference for quality and precision in this segment.
Our systems aim to be used for oral, vaginal and rectal treatments such as Oral infections, Vaginal infections, and Rectal diseases.

With RetroNose®, enhance therapeutic efficacy of your nasal drug with a better deposition

Safe'n'Spray™: the integrated device with reusable electronic locking unit and fingerprint identification, to monitor drug delivered and prevent overdosing. Normal 0 21 false false false FR X-NONE X-NONE ...

More modern, our new brand identity truly embodies who we are, how we partner with our customers and ultimately the value we bring to millions of patients across the world through our drug delivery device solutions.

The Innovation in Connectivity Roundtable originally aired as part of Pharmapack Europe 2021 Part 1 of this session includes three presentations: Patient Journey Driven Considerations for Integrating Digital Health for Combination Products The importance of utilizing applied ethnography and other primary research methods to understand the patient journey as the foundation for integrating digital health into a device/combination product development initiative. Considering patient needs in the context of a larger ecosystem including providers, payers, and regulators to develop a robust plan with respect to connectivity and digital health. Examples of how this understanding is applied across the combination product development journey through organic development, utilization of platform devices, or as a lifecycle management enchantments while optimizing the user experience resulting in safe, effective, and differentiated combination products. Mark Tunkel, Global Category Director for Insight Innovation, Nemera Electronic Product Information: A Case Study on Medicine Labelling for the Visually Impaired The Electronic Product Information Initiative for Medicines (ePI) aim to ease the accessibility of product information to everyone, including visually impaired patients. The GS1 Digital Link aim to provide a single barcode for identification, brand protection, and access to product information for patients. Our lecture will illustrate how the existing Datamatrix on packaging could be leveraged, today, by everyone, including visually impaired users, to access a tailored and relevant information. Laurent Tonnelier, CEO, mobiLead - xTag Lise Wagner, Accessibility Specialist and User Expert, OKEENEA Traceability of Medicines: from Finished Product to Unit Dose Delivery Challenges for B2B Supply Chain stakeholders Regulations: a global overview What about B2C Nathalie Wardé, CEO & Founder, D4P pharma Join the above speakers and moderator Lionel Jeannin, Group Head Oral Packaging & Delivery Systems, Novartis Pharma AG for the live panel discussion that followed in the Innovation in Connectivity Roundtable pt. 2